Associated Papers
de novo variant calling identifies cancer mutation signatures in the 1000 Genomes Project.
Ng JK et al.
Human Mutation, 2022
36054329 (PubMed )
Supplement: HUMU-43-1979-s002.xlsx › S14_IGLL5_DNVs
Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma.
Li SS et al.
Experimental Hematology & Oncology, 2022
36243813 (PubMed )
Supplement: 40164_2022_325_MOESM5_ESM.xlsx › Sheet1
T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma.
Wang J et al.
Frontiers in Immunology, 2022
35572515 (PubMed )
Supplement: Table_2.xlsx › S5
Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
González-Rincón J et al.
Plos One, 2019
30802265 (PubMed )
Supplement: pone.0212813.s010.xlsx › Tabla_S4.SNV___Indel
Select a paper to view details